Skip to main content

Featured

Interparfums FY 2022: record earnings as operating profit soars 33 percent

THE WHAT? Interparfums has reported its results for the 2022 fiscal year. The fragrance giant recorded record earnings for the full year with net income up 40 percent on 2021’s figures and sales rising 26 percent to €706.6 million. THE DETAILS The company noted that it had extended its partnership with Montblanc until December 31, 2030 and, subject to the General Meeting’s ratification, hit its goal of achieving gender parity on its board. THE WHY? Philippe Benacin, Chairman and CEO, commented, “Against the backdrop of a turbulent economic and geopolitical environment, our sales and earnings continued to grow in 2022. In 2023, although many uncertainties still exist, this positive momentum should continue with sales expected to reach €750 million, driven by the continuing appeal of our brands for consumers in a global perfume market that remains buoyant.” The post Interparfums FY 2022: record earnings as operating profit soars 33 percent appeared first on Global Cosme
1 comment
Read more

Adaptive Clinical’s Tope Keyes on clinical trials in the COVID-19 era (podcast)

TK head shot 1
Temitope Keyes

Thanks to COVID-19, the era of decentralized trials is now upon us. In this podcast interview, Adaptive Clinical Systems‘ Temitope Keyes and I discuss how trials are changing and what clinical data infrastructure is needed to make them flow smoothly.

Questions include:

  • Changes are underway in clinical trials right now as a result of COVID-19
  • The imperative for “frictionless clinical data.”
  • Ensure optimal performance in the new environment
  • New data sources and endpoints that will be employed
  • Technological innovations that we can expect

Tope will be a panelist on a webinar I’m moderating on July 8: Moving Clinical Trials Forward with Digital Innovation in the COVID Era. We’ll be joined by Mark Mann of The Oxenham Group and Bob O’Hara of ResultWorks. Please register –the webinar is complimentary.

By healthcare business consultant David E. Williams, president of Health Business Group.

The post Adaptive Clinical’s Tope Keyes on clinical trials in the COVID-19 era (podcast) appeared first on Health Business Group.



* This article was originally published here

Comments

Post a Comment

Popular Posts